Table 1 Demographic and biochemical features of the study groups
Demographic and biochemical features | Group I controls(n = 30) | Group II diabetics without complications(n = 30) | Group III diabetics with PVD(n = 30) |
|---|---|---|---|
Mean age (years) | 51 ± 0.1 | 50 ± 0.9 | 51 ± 1.1 |
Fasting blood glucose level (mmol/dl) | 5.7 ± 0.1 | 6.7 ± 1.65 | 9.6 ± 1.7*¥ |
Postprandial serum glucose level (mmol/dl) | 5.8 ± 0.11 | 7.1 ± 0.41 | 10.4 ± 0.62*¥ |
Disease duration (years) |  | 9.7 ± 0.1 | 10.3 ± 1.0 |
HbA1c (%) | 5.5 ± 0.2 | 6.6 ± 0.2 | 9.4 ± 0.2* |
Lipid profile | Â | Â | Â |
Cholesterol (mmol/l) | 4.8 ± 0.3 | 5.2 ± 0.2 | 5.5 ± 1.1 |
Triglycerides (mmol/l) 2.01 ± 0.09 | 1.9 ± 0.3 | 1.9 ± 0.04 | 2.08 ± 0.04 |
BMI (kg/m2) | 25 ± 1.4 | 29 ± 1.5* | 30 ± 1.1* |
Kidney function | Â | Â | Â |
Creatinine (μmol/l) | 87.9 ± 4.6 | 93.1 ± 2.14 | 99.7 ± 1.8 |
Urea (mmol/l) | 4.5 ± 0.6 | 5.0 ± 0.13 | 5.7 ± 0.6 |
Treatment | Â | Oral hypoglycemics (metformin and/or gliclazide) | Oral hypoglycemics (metformin and/or gliclazide) |